✦ LIBER ✦

Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial

✍ Scribed by Faderl, S.; Wetzler, M.; Rizzieri, D.; Schiller, G.; Jagasia, M.; Stuart, R.; Ganguly, S.; Avigan, D.; Craig, M.; Collins, R.; Maris, M.; Kovacsovics, T.; Goldberg, S.; Seiter, K.; Hari, P.; Greiner, J.; Vey, N.; Recher, C.; Ravandi, F.; Wang, E. S.; Vasconcelles, M.; Huebner, D.; Kantarjian, H. M.

Book ID: 111922182
Publisher: American Society of Clinical Oncology
Year: 2012
Tongue: English
Weight: 157 KB
Volume: 30
Category: Article
ISSN: 0732-183X
DOI: 10.1200/jco.2011.37.9743

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II trial of clofarabine and cyta

Phase I/II trial of clofarabine and cytarabine in children with relapsed/refractory acute lymphoblastic leukemia (AAML0523): A report from the Children's Oncology Group

✍ Cooper, Todd M.; Razzouk, Bassem I.; Gerbing, Robert; Alonzo, Todd A.; Adlard, K 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

Combination of topotecan with cytarabine

Combination of topotecan with cytarabine or etoposide in patients with refractory or relapsed acute myeloid leukemia: Results of a randomized phase I/II study

✍ Norbert Vey; Hagop Kantarjian; Miloslav Beran; Susan O'Brien; Jorge Cortes; Char 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 67 KB

A Phase I Trial of Lenalidomide in Combi

A Phase I Trial of Lenalidomide in Combination with Intermediate Dose Cytarabine (IDC) in Relapsed or Refractory Acute Myeloid Leukemia (AML) Patients

✍ Vigil, Carlos E.; Griffiths, Elizabeth A.; Thompson, James E.; Brady, William E. 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 64 KB

A phase I trial of a single high dose of

A phase I trial of a single high dose of idarubicin combined with high-dose cytarabine as induction therapy in relapsed or refractory adult patients with acute lymphoblastic leukemia

✍ Weiss, M A; Drullinsky, P; Maslak, P; Scheinberg, D; Golde, D W 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 42 KB

Subsequent Hematopoietic Stem Cell Trans

Subsequent Hematopoietic Stem Cell Transplantation (HSCT) Associated with Longer Survival in Patients with Relapsed/Refractory (R/R) Acute Myelogenous Leukemia (AML) After Clo+Ara-C or Ara-C Alone: A Landmark Analysis from the Classic I Trial

✍ S. Ganguly; H.M. Kantarjian; M. Wetzler; D. Rizzieri; G. Schiller; M. Hagasia; R 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Clofarabine in combination with a standa

Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial)

✍ Willemze, R.; Suciu, S.; Muus, P.; Halkes, C. J. M.; Meloni, G.; Meert, L.; Karr 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 197 KB